Trial · NCT00471237
Adverse events371
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 371
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Placebo | 17 | 90 | |
| other | Nasopharyngitis | Infections and infestations | Ronacaleret, 100 mg Tablet, OD | 16 | 87 | |
| other | Nasopharyngitis | Infections and infestations | Ronacaleret, 200 mg Tablet, OD | 13 | 82 | |
| other | Nasopharyngitis | Infections and infestations | Ronacaleret, 300 mg Tablet, OD | 12 | 88 | |
| other | Nasopharyngitis | Infections and infestations | Ronacaleret, 400 mg Tablet, OD | 16 | 87 | |
| other | Nasopharyngitis | Infections and infestations | Alendronate, 70 mg, Capsule, OW | 12 | 89 | |
| other | Nasopharyngitis | Infections and infestations | Teriparatide, 20 mcg, SC Injection, OD | 7 | 41 | |
| other | Influenza | Infections and infestations | Placebo | 7 | 90 | |
| other | Influenza | Infections and infestations | Ronacaleret, 100 mg Tablet, OD | 6 | 87 | |
| other | Influenza | Infections and infestations | Ronacaleret, 200 mg Tablet, OD | 5 | 82 | |
| other | Influenza | Infections and infestations | Ronacaleret, 300 mg Tablet, OD | 6 | 88 | |
| other | Influenza | Infections and infestations | Ronacaleret, 400 mg Tablet, OD | 9 | 87 | |
| other | Influenza | Infections and infestations | Alendronate, 70 mg, Capsule, OW | 7 | 89 | |
| other | Influenza | Infections and infestations | Teriparatide, 20 mcg, SC Injection, OD | 4 | 41 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 5 | 90 | |
| other | Upper respiratory tract infection | Infections and infestations | Ronacaleret, 100 mg Tablet, OD | 5 | 87 | |
| other | Upper respiratory tract infection | Infections and infestations | Ronacaleret, 200 mg Tablet, OD | 4 | 82 | |
| other | Upper respiratory tract infection | Infections and infestations | Ronacaleret, 300 mg Tablet, OD | 2 | 88 | |
| other | Upper respiratory tract infection | Infections and infestations | Ronacaleret, 400 mg Tablet, OD | 8 | 87 | |
| other | Upper respiratory tract infection | Infections and infestations | Alendronate, 70 mg, Capsule, OW | 3 | 89 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00471237/events